Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
Impotencia throughout the ages.

The Journal of the American Society of Psychosomatic Dentistry and Medicine

Herman JR.
PMID: 4913355
J Am Soc Psychosom Dent Med. 1969;16(3):93-9.

No abstract available.

Erectile dysfunction.

Journal of the Indian Medical Association

Jaiswal A.
PMID: 11394479
J Indian Med Assoc. 2000 Dec;98(12):792-4.

No abstract available.

Psychological management of erectile dysfunction in primary care.

The National medical journal of India

Gopalakrishnan R, Kurian S, Jacob KS.
PMID: 16433147
Natl Med J India. 2005 Sep-Oct;18(5):274.

No abstract available.

[Advances in the studies of refractory erectile dysfunction].

Zhonghua nan ke xue = National journal of andrology

Wang BY, Jiang R.
PMID: 23469669
Zhonghua Nan Ke Xue. 2013 Jan;19(1):82-5.

Erectile dysfunction (ED) is a common problem, for which PDE5 inhibitors (PDE5I) represent the first line therapy at present and have a success rate of approximately 80%. Refractory ED, which refers to ED in some patients with chronic diseases...

Re: management of ED under the "severe distress" criteria in the NHS: a real-life study.

The Journal of urology

Seftel AD.
PMID: 25280310
J Urol. 2014 Jun;191(6):1841-2. doi: 10.1016/j.juro.2014.03.059. Epub 2014 Mar 20.

No abstract available.

[Phosphodiesterase-5 inhibitors for erectile dysfunction: Adverse reactions and countermeasures].

Zhonghua nan ke xue = National journal of andrology

Jiang R, Wu BC.
PMID: 26939391
Zhonghua Nan Ke Xue. 2016 Feb;22(2):99-103.

Phosphodiesterase-5 inhibitors (PDE5i) have been used as the first-line treatment for erectile dysfunction (ED) in recent years. However, with the increased clinical application of PDE5i, the incidence rate of PDE5i-induced adverse reactions is on the rise, which may involve...

Erectile Dysfunction/Impotence: An Update of Drugs, Drug Delivery/Management, and Approaches or Strategies.

Skinmed

Sehgal VN.
PMID: 31627787
Skinmed. 2019 Jul 01;17(4):256-259. eCollection 2019.

Erectile dysfunction/impotence, a universal phenomenon, is a type of sexual dysfunction, the incidence of which is unknown. Certainly, its management options has changing scenario, in particular, take cognizance of phosphodiesterase type 5 inhibitors being the pivot, the highlight of...

Preference for erectile dysfunction treatments: Assessment by means of consumers preference analysis techniques.

Actas urologicas espanolas

Gutiérrez-Hernández PR, Rebollo P.
PMID: 24332530
Actas Urol Esp. 2014 Jun;38(5):319-26. doi: 10.1016/j.acuro.2013.11.001. Epub 2013 Dec 12.

INTRODUCTION: Patient preference for erectile dysfunction (ED) treatments is of great importance for satisfaction and adherence. We have assessed the usefulness of the main technique for assessing consumer preferences (conjoint analysis) to analyze preferences towards these treatments. We also...

Consulting "Dr Google" for sexual dysfunction: a contemporary worldwide trend analysis.

International journal of impotence research

Russo GI, di Mauro M, Cocci A, Cacciamani G, Cimino S, Serefoglu EC, Albersen M, Capogrosso P, Fode M, Verze P.
PMID: 31591474
Int J Impot Res. 2020 Jul;32(4):455-461. doi: 10.1038/s41443-019-0203-2. Epub 2019 Oct 07.

Google Trends (GT) is a free, easily accessible search tool which can be used to analyze worldwide "big data" on the relative popularity of search terms over a specific period of time. To determine worldwide public interest in Peyronie'...

[Erectile dysfunction. Another option].

Perspective infirmiere : revue officielle de l'Ordre des infirmieres et infirmiers du Quebec

Sabourin G.
PMID: 22097429
Perspect Infirm. 2011 Nov-Dec;8(6):56.

No abstract available.

Showing 1 to 10 of 10 entries